MAL12115057AZPrescription (MAL-A)

IRBEL HCT TABLETS 150 + 12.5 mg

Generic Molecule: Irbesartan 150 mg & Hydrochlorothiazide 12.5 mg tablet

ACTIVE & APPROVEDValid till: 1 Dec 2027
NPRA Official Regulatory Summary

IRBEL HCT TABLETS 150 + 12.5 mg is a KKM-approved Prescription Medicine registered under MAL number MAL12115057AZ by RANBAXY (MALAYSIA) SDN. BHD.. Its active ingredient is IRBESARTAN 150.000mg 0, HYDROCHLOROTHIAZIDE 12.500mg 0, manufactured by Sun Pharmaceutical Industries Limited.

Holder (PRH)
RANBAXY (MALAYSIA) SDN. BHD.
Manufacturer
Sun Pharmaceutical Industries Limited
First Registered
1 Dec 2022
Validity
1 Dec 2027

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
IRBESARTAN150.000mg 0Find Brands
HYDROCHLOROTHIAZIDE12.500mg 0Find Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL12115057AZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is IRBEL HCT TABLETS 150 + 12.5 mg approved by KKM / NPRA?

Yes. IRBEL HCT TABLETS 150 + 12.5 mg is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL12115057AZ with current status PRODUCT APPROVED. Registration was filed by RANBAXY (MALAYSIA) SDN. BHD..

What are the active ingredients of IRBEL HCT TABLETS 150 + 12.5 mg?

The declared active therapeutic components are: IRBESARTAN 150.000mg 0, HYDROCHLOROTHIAZIDE 12.500mg 0. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 47 registered brand formulations containing identical active ingredients (Irbesartan). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: IRBEL HCT TABLETS 150 + 12.5 mg (MAL12115057AZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.